Mark S. Levine - Aug 17, 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Chief Legal Officer
Signature: /s/ Eva Renee Barnett, attorney-in-fact for Mark Levine
Stock symbol: IMVT
Transactions as of: Aug 17, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/19/2022, 04:57 PM
Previous filing: Jan 31, 2022
Next filing: Jan 27, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Award	$0	+113K	+78.89%	$0.00	256K	Aug 17, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMVT	Stock Option (right to buy)	Award	$0	+170K		$0.00	170K	Aug 17, 2022	Common Stock	170K	$4.99	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares underlying restricted stock units awards ("RSUs").
F2	The RSUs vest over four years, with 25% of the RSUs vesting on August 17, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
F3	Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on August 17, 2023 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.